Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -40.18% is in line with its 1-year average of -42.25%, around the middle of its 1-year range (-81.91%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -44.85%.
NET PROFIT MARGIN
-40.18%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alamar Biosciences, Inc.
Market Cap
$2.52B
Net Profit Margin
-40.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.60B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.45B
Net Profit Margin
30.74%
TTM Avg
-487.59%
3Y Avg
-420.36%
5Y Avg
-1671.77%
Market Cap
$2.44B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.40B
Net Profit Margin
-0.74%
TTM Avg
-3.79%
3Y Avg
-13.87%
5Y Avg
-19.28%
Market Cap
$2.40B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.67B
Net Profit Margin
-33.44%
TTM Avg
-12.59%
3Y Avg
-3.87%
5Y Avg
-6.56%
Market Cap
$2.71B
Net Profit Margin
10.56%
TTM Avg
9.25%
3Y Avg
0.54%
5Y Avg
-8.48%
Market Cap
$2.71B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.52B | -40.18% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -54.75% | -325.19% | -290.00% | -135445.82% |
| Liquidia Corporation (LQDA)vs › | $2.45B | 30.74% | -487.59% | -420.36% | -1671.77% |
| Disc Medicine, Inc. (IRON)vs › | $2.44B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | -0.74% | -3.79% | -13.87% | -19.28% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.40B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | -33.44% | -12.59% | -3.87% | -6.56% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.71B | 10.56% | 9.25% | 0.54% | -8.48% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | 0.00% | 0.00% | 0.00% | 0.00% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.33B | 32.98% | 37.58% | 5.36% | -41.08% |
Operating Margin
-42.2%
Net Profit Margin
-40.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -44.85% |
| 2026-03-31 | -81.91% |
| 2025-12-31 | 0.00% |
